Company: MDCXW
Filing Date: 2025-11-19
Form Type: S-1
Source: 0001062993-25-016962
Chunk: 243

Company: Medicus Pharma Ltd.
Filing Date: 2025-11-19
Form: S-1
Chunk 243
---
 |   |    585,442 |     |   |             |   |   |               |     |   |             |     |   |    585,442 |   |
| Net loss and comprehensive loss for the period |     |             - |     |   |          - |     | -                   |     |   | -      |     |   |            |     |   | (3,632,859  | ) |   | -             |     |   | -           |     |   | (3,632,859 | ) |
| Balance as of June 30, 2024                    |     |    10,846,721 |     |   | 29,442,212 |     | -                   |     |   | -      |     |   |    719,980 |     |   | (23,088,604 | ) |   | -             |     |   | -           |     |   |  7,073,588 |   |
| Net loss and comprehensive loss for the period |     |             - |     |   |          - |     | -                   |     |   | -      |     |   |          - |     |   | (2,278,747  | ) |   | -             |     |   | -           |     |   | (2,278,747 | ) |
| Balance, September 30, 2024                    |     |    10,846,721 |     | $ | 29,442,212 |     | -                   |     | $ | -      |     | $ |    719,980 |     | $ | (25,367,351 | ) | $ | -             |     | $ | -           |     | $ |  4,794,841 |   |

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

<div align='center'>F-29

MEDICUS PHARMA LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)</div>

| Cash flows from operating activities:                                       |   | Nine months ended September 30, 
                            2025 |   |   |       2024 |   |
|:----------------------------------------------------------------------------|:--|--------------------------------:|:--|:--|-----------:|:--|
| Net loss for the period                                                     | $ |                     (